Abstract
Buspirone and gepirone were evaluated as potential pharmacotherapies for cocaine abuse by studying the effects of acute and repeated treatment on IV cocaine self-administration in rhesus monkeys. Chlorpromazine was also evaluated as a positive control. Effects of IV drug pretreatments were tested during daily 60-min sessions with lever-pressing reinforced under a fixed-ratio 10 schedule of 0.02 or 0.05 mg/kg cocaine infusions. Acute pretreatment with buspirone (0.1 and 0.3 mg/kg, IV) increased rates of cocaine self-administration without disrupting food pellet consumption. Some doses of buspirone also produced changes in rates of cocaine self-administration without altering the within-session pattern of responding. In contrast, acute doses of gepirone had little effect on rates of cocaine self-administration, while disruptions in food consumption and changes in the within-session pattern of cocaine self-administration were obtained at the highest dose of gepirone tested (1.0 mg/kg). When either buspirone (0.1 and 0.3 mg/kg, IV) or gepirone (0.1 mg/kg, IV) were administered daily for 10 days, consistent effects on cocaine self-administration were not observed. Thus, the effects of acute buspirone administration on cocaine-maintained behavior were similar to the effects produced by chlorpromazine and other dopaminergic antagonists, whereas, gepirone was ineffective. These results provide some support for further evaluation of buspirone as a potential pharmacotherapy for cocaine abuse, although its lack of efficacy with repeated treatment is not encouraging. The negative results with gepirone provide less rationale for continued investigations with this drug, possibly because of its lesser involvement than buspirone with dopaminergic neurotransmission.
Similar content being viewed by others
References
Ator NA (1991) Discriminative stimulus effects of the novel anxiolytic buspirone. Behav Pharmacol 2:3–14
Balster RL (1990) Abuse potential of buspirone and related drugs. J Clin Psychopharmacol 10:31S-37S
Bueno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology 22[suppl 1]:49–59
Collins DM, Myers RD (1987) Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol 4:49–56
Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30–43
Eison MS, Yevich JP, Farney RF (1985) Gepirone hydrochloride. Drugs of the Future 10:456–457
Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms of buspirone and gepirone. Pharmacol Biochem Behav 24:701–707
Gawin F, Compton M, Byck R (1989) Buspirone reduces smoking. Arch Gen Psychiatry 46:288–289
Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkey. Bull Narc 30:43–54
Kamien JB, Woolverton WL (1990) Buspirone blocks the discriminative stimulus effects of apomorphine in monkeys. Pharmacol Biochem Behav 35:117–120
Koenig JI, Meltzer HY, Gudelsky GA (1988) 5-Hydroxytryptamine 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 29:711–715
McMillan BA, Mattiace LA (1983) Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug. J Neural Transm 57:255–265
Nader MA, Barrett JE (1990) Effects of chlordiazepoxide, buspirone, and serotonin receptor agonists and antagonists on responses of squirrel monkeys maintained under second-order schedules of intramuscular cocaine injection or food presentation. Drug Dev Res 20:5–17
New JS (1990) The discovery and development of buspirone: a new approach to the treatment of anxiety. Med Res Rev 10:283–326
Privette TU, Hornsby RL, Myers RD (1988) Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 5:147–152
Taylor DP (1988) Buspirone, a new approach to the treatment of anxiety. FASEB J 2:2445–2452
Wilson MC, Schuster CR (1972) The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia 26:115–126
Wilson MC, Schuster CR (1973) The effects of stimulants and depressants on cocaine self-administration behavior in the rhesus monkey. Psychopharmacologia 31:291–304
Woolverton WL (1986) Effects of a D1 and D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24:531–535
Yevich JP, Temple DL Jr., New JS, Taylor DP, Riblet LA (1983) Buspirone analogues. 1. Structure-activity relationships of a series ofN-aryl-and heteroarylpiperazine derivatives. J Med Chem 28:194–203
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gold, L.H., Balster, R.L. Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys. Psychopharmacology 108, 289–294 (1992). https://doi.org/10.1007/BF02245114
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245114